Impact of Genetic Polymorphisms on Electrochemical Parameters and Acid-Base Disorders in Brazilian Runners During a 105-Kilometer Ultramarathon
Nutrients · 2024
DOI: 10.3390/nu16223945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Marcelo Romanovitch Ribas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Electrical Engineering and Industrial Informatics, Universidade Tecnológica Federal do Paraná, Curitiba 80230901, Brazil. Hauptthemen laut MEDLINE: Polymorphism, Genetic. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: This study focused on a group of 22 elite male mountain runners from Brazil (average age of 35.9 ± 6.5 years) with the objective of exploring the possible roles of the ACTN3 R577X, ACE I/D, and CK MM A/G NcoI genetic variants in shaping electrochemical profiles and maintaining acid-base homeostasis during a 105-km ultramarathon.
Methods
Genotyping for each polymorphism (ACTN3: RR, RX, XX; ACE: DD, ID, II; CK MM: AA, AG, GG) was conducted using PCR-RFLP (Polymerase Chain Reaction-Restriction Fragment Length Polymorphism), and saliva samples were used to obtain DNA. Analyses of electrochemical and acid-base disturbances were performed in real time.
Results
It was observed that athletes who completed the race in less time had lower calcium concentrations (Rs = 0.35; p = 0.016). Pre-race, the RX genotype showed a 14.19% reduction in potassium levels compared to RR (p = 0.01). The GG genotype showed potassium levels 19.36% higher than AA (p = 0.01) and a 6.11% increase in hematocrit values compared to AA (p = 0.03). Additionally, the AG genotype exhibited hematocrit values 5.44% higher than AA (p = 0.03). Post-race, the XX genotype demonstrated higher hematocrit values compared to RX, with an increase of 8.92% (p = 0.03). The II genotype showed a 0.27% increase in pH compared to ID (p = 0.02) and a 20.42% reduction in carbon dioxide levels (p = 0.01).
Conclusions
The findings emphasize the impact of the examined polymorphisms on the modulation of electrochemical factors and the maintenance of acid-base equilibrium in athletes during 105 km ultramarathons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Electrical Engineering and Industrial Informatics, Universidade Tecnológica Federal do Paraná, Curitiba 80230901, Brazil.
- Human Genetics Laboratory, Centro Universitário Autônomo do Brasil (UniBrasil), Curitiba 82821020, Brazil.
- Department of Physical Education and Special Motricity, Faculty of Physical Education and Mountain Sports, Transilvania University of Braşov, 500068 Braşov, Romania.
- Postgraduate Program in Physical Education, Universidade Tecnológica Federal do Paraná, Curitiba 81310900, Brazil.
- Department of Teacher Education, NLA University College, 0166 Oslo, Norway.
ORCID-Profile: Fábio Kurt Schneider, Georgian Badicu, Luca Paolo Ardigò, Júlio Cesar Bassan
Zitieren
APA
Ribas, M. R., Schneider, F. K., Ribas, D. I. R., Badicu, G., Bonatto, A. C., Ardigò, L. P., & Bassan, J. C. (2024). Impact of Genetic Polymorphisms on Electrochemical Parameters and Acid-Base Disorders in Brazilian Runners During a 105-Kilometer Ultramarathon. Nutrients. https://doi.org/10.3390/nu16223945
Vancouver
Ribas MR, Schneider FK, Ribas DIR, Badicu G, Bonatto AC, Ardigò LP, et al. Impact of Genetic Polymorphisms on Electrochemical Parameters and Acid-Base Disorders in Brazilian Runners During a 105-Kilometer Ultramarathon. Nutrients. 2024. doi:10.3390/nu16223945
BibTeX
@article{Ribas2024,
author = {Ribas, Marcelo Romanovitch and Schneider, Fábio Kurt and Ribas, Danieli Isabel Romanovitch and Badicu, Georgian and Bonatto, Ana Claudia and Ardigò, Luca Paolo and Bassan, Júlio Cesar},
title = {Impact of Genetic Polymorphisms on Electrochemical Parameters and Acid-Base Disorders in Brazilian Runners During a 105-Kilometer Ultramarathon},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16223945}
}
EUVIMED